COMPOSITION BASED ON ALKALOID HAVING EBURNAMENINE NUCLEUS FOR STIMULATION OF CEREBRAL ACTIVITY AND METHOD FOR PREPARING THE SAME

Japanese Patent JP2008056681

A

To provide a new composition for stimulating cerebral activity for use in oral administration.

The new composition is based on the discovery of the potent action that certain alkaloids with an eburnamenine nucleus have when they are administered in association with compounds having a xantine structure. A synergic potent action in the cognoscitive capacity is obtained and, consequently the cerebral activity is reinforced in general in the short and long term following the oral administration of the above composition. The composition contains 0.5-10 mg of alkaloids or extract of alkaloids of the eburnamenine type per 100 ml of beverage of cola, lemon, cocoa, ginseng, tonic water, coffee or any other beverage obtained from extracts, or 0.4-30 mg of alkaloids or extracts of alkaloids of the eburnamenine type per 5-20 g of dry, semi-dry or wet extract of coffee, cola, cocoa, tea, ginseng, tonic water or any other extract for beverages.

LAZARO FLORES CONSUELO
CALVO LAZARO PAULA
CALVO LAZARO ELENA
MANRESA FERRERO MARIA TERESA
CALVO MONDELO FERNANDO

JP2007247938A

March 13, 2008

September 25, 2007

Click for automatic bibliography generation  

DECOX SL

A61K31/4375; A01N43/42; A23F3/16; A23F3/30; A23F5/40; A23G1/00; A23G1/56; A23L1/30; A23L2/02; A23L2/38; A23L2/52; A23L27/20; A61K9/08; A61K31/475; A61K31/519; A61K31/52; A61K31/522; A61K36/00; A61K36/18; A61K36/185; A61K36/25; A61K36/258; A61K36/74; A61K36/82; A61K47/00; A61P25/00; A61P25/26; A61P25/28; A61P43/00; C07D471/22

EP0154756A1	1985-09-18
ES8505677A1	1985-06-16

Takashi Ishida
Yoshio Yoshio
Masaya Nishiyama

Previous Patent: GLUTATHIONE-S-TRANSFERASE-ACTIVATED COMPOUND

Next Patent: PHARMACEUTICAL COMPOSITION FOR TREATING PAIN ASSOCIATED WITH MUSCULAR DISEASE